{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:25:55Z","timestamp":1789053955169,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.suc.2023.07.002","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:08:06Z","timestamp":1692263286000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Donor Viral Hepatitis and Liver Transplantation"],"prefix":"10.1016","volume":"104","author":[{"given":"Sara-Catherine Whitney","family":"Zingg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2023.07.002_bib1","unstructured":"Services USDoHaH. Organ Procurement and Transplantation Network 2023 (updated 30 March 2023). Available at: https:\/\/optn.transplant.hrsa.gov\/data\/. Accessed 30 March 2023."},{"issue":"Issue 2","key":"10.1016\/j.suc.2023.07.002_bib2","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 20121 Annual Data Report: Liver","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib3","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MOT.0000000000000850","article-title":"The Current Status of Virus-Positive Liver Transplantation","volume":"26","author":"Delman","year":"2021","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib5","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.3748\/wjg.v25.i47.6799","article-title":"Expanding the donor pool: hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation","volume":"25","author":"Crismale","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2023.07.002_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0016-5085(92)91129-R","article-title":"Recurrent and Acquired Hepatits C Viral Infection in Liver Transplant Recipients","volume":"103","author":"Wright","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2023.07.002_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0016-5085(99)70561-5","article-title":"Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts","volume":"117","author":"Vargas","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2023.07.002_bib8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/jlts.2001.27088","article-title":"Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis Cnegative livers","volume":"7","author":"Marroquin","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.suc.2023.07.002_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","article-title":"Long-term follow-up and outcome of liver transplantation from antihepatitis C virus-positive donors: a European multicentric case-control study","volume":"91","author":"Ballarin","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.suc.2023.07.002_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C-infected donor livers in the recent era","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/lt.25424","article-title":"Improved graft survival after liver transplantation for recipients with hepatitis C virus in the direct-acting antiviral era","volume":"25","author":"Cotter","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.suc.2023.07.002_bib12","first-page":"122","article-title":"Transplantation of HCV viremic livers into HCV viremic recipients followed by direct-acting antiviral therapy","volume":"7","author":"Kapila","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1034\/j.1600-6143.2003.00189.x","article-title":"Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis","volume":"3","author":"Saab","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/TP.0000000000003014","article-title":"Liver and kidney recipient selection of hepatitis C virus viremic donors: meeting Consensus Report from the 2019 controversies in transplantation","volume":"104","author":"Burton","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.suc.2023.07.002_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MOT.0000000000000848","article-title":"Hepatitis C-positive Liver Transplantation: Outcomes and Current Practice","volume":"26","author":"Danford","year":"2021","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib16","doi-asserted-by":"crossref","first-page":"e13194","DOI":"10.1111\/tid.13194","article-title":"Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients","volume":"21","author":"Ting","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.suc.2023.07.002_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jamcollsurg.2018.12.004","article-title":"Use of hepatitis C virus antibody-positive donor livers in hepatitis C nonviremic liver transplant recipients","volume":"228","author":"Luckett","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.suc.2023.07.002_bib18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cgh.2018.09.036","article-title":"Increasing trends in transplantation of HCV-positive livers into uninfected recipients","volume":"17","author":"Cholankeril","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.suc.2023.07.002_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.29704","article-title":"Hepatitis C Transmission from Seropositive, Nonviremic Donors to Non-Hepatitis C Liver Transplant Recipients","volume":"67","author":"Bari","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2023.07.002_bib20","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hep.30540","article-title":"Increasing utilization and excellent initial outcomes following liver transplant of hepatitis C virus (HCV)-viremic donors into HCV-negative recipients: outcomes following liver transplant of HCVviremic donors","volume":"69","author":"Cotter","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2023.07.002_bib21","unstructured":"Centers for Disease Control and Prevention. Surveillance for viral hepatitis\u2014United States, 2016. Available at: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2016surveillance\/pdfs\/2016Hep SurveillanceRpt.pdf. Accessed 30 March 2023."},{"issue":"4","key":"10.1016\/j.suc.2023.07.002_bib22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.30046","article-title":"Glecaprevir\/Pibrentasvir Treatment in Liver or Kidney Transplant Patients with Hepatitis C Virus Infection","volume":"64","author":"Reau","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2023.07.002_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrgastro.2011.57","article-title":"Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis","volume":"8","author":"Fink","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-med-052915-015720","article-title":"Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs","volume":"68","author":"Naggie","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.suc.2023.07.002_bib25","unstructured":"American Association for the Study of Liver Disease and Infectious Disease Society of America. HCV Guidance Panel. Recommendations for testing, managing, and treating hepatitis C. Published 2017. Available at: http:\/\/hcvguidelines.org. Accessed April 19, 2023."},{"key":"10.1016\/j.suc.2023.07.002_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","article-title":"Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis","volume":"67","author":"Kwo","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cgh.2017.09.027","article-title":"Efficacy of glecaprevir\/pibrentasvir for 8 or 12\u00a0weeks in patients with hepatitis C virus genotype 2, 4, 5, or 6 infection without cirrhosis","volume":"16","author":"Asselah","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa1702417","article-title":"Glecaprevir-pibrentasvir for 8 or 12\u00a0weeks in HCV genotype 1 or 3 infection","volume":"378","author":"Zeuzem","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2023.07.002_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.29081","article-title":"Glecaprevir and pibrentasvir for 12\u00a0weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment","volume":"66","author":"Poordad","year":"2017","journal-title":"Hepatology"},{"issue":"27","key":"10.1016\/j.suc.2023.07.002_bib30","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"ASTRAL-2 Investigators; ASTRAL-3 Investigators. Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.suc.2023.07.002_bib31","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"ASTRAL-1 Investigators. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.suc.2023.07.002_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/liv.13193","article-title":"Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis","volume":"37","author":"Martini","year":"2017","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.suc.2023.07.002_bib33","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2018.03.022","article-title":"Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for hepatitis C virus infection","volume":"154","author":"El-Sherif","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.suc.2023.07.002_bib34","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.15162","article-title":"Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors","volume":"19","author":"Kwong","year":"2019","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.suc.2023.07.002_bib35","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/ajt.15768","article-title":"Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: implications for therapeutic planning","volume":"20","author":"Bethea","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.suc.2023.07.002_bib36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/lt.25925","article-title":"Liver transplantation using hepatitis C virus\u2013viremic donors into hepatitis C virus\u2013aviremic recipients as standard of care","volume":"27","author":"Bohorquez","year":"2021","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.suc.2023.07.002_bib37","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/hep.31551","article-title":"Prospective multicenter study of early antiviral therapy in liver and kidney transplant recipients of HCV-viremic donors","volume":"73","author":"Terrault","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suc.2023.07.002_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2020.11.005","article-title":"Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients","volume":"74","author":"Aqel","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib39","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jhep.2019.03.003","article-title":"Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis","volume":"70","author":"Wong","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MOT.0000000000000810","article-title":"Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors","volume":"25","author":"Zhou","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2023.07.002_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(92)90138-F","article-title":"Hepatitis B Virus Reinfection After Orthotopic Liver Transplantation","volume":"14","author":"O\u2019Grady","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","article-title":"Liver grafts from antihepatitis B core positive donors: a systematic review","volume":"52","author":"Cholongitas","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib44","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1111\/j.1399-0012.2011.01409.x","article-title":"Risk of De Novo Hepatitis in Liver Recipients from Hepatitis-B Core Antibody-Positive Grafts \u2013 A Systemic Analysis","volume":"25","author":"Skagen","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib45","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid Organ Transplantation From Hepatitis B Virus Positive Donors: Consensus Guidelines for Recipient Management","volume":"5","author":"Huprikar","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.6002\/ect.2012.0095","article-title":"Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus","volume":"11","author":"Ju","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.suc.2023.07.002_bib47","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jvh.12972","article-title":"Long-term Outcome and Recurrence of Hepatitis B Virus Following Liver Transplantation from Hepatitis B Surface Antigen-Positive Donors in a Chinese Population","volume":"25","author":"Wei","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.suc.2023.07.002_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.transproceed.2012.05.077","article-title":"Liver transplantation from hepatitis B surface antigen-positive donors","volume":"45","author":"Saidi","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.suc.2023.07.002_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/lt.23774","article-title":"Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database","volume":"20","author":"Li","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.suc.2023.07.002_bib50","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/jgh.15821","article-title":"Utilization of Hepatitis B Virus Surface Antigen Positive Grafts in Liver Transplantation: A Matched Study Based on a National Registry Cohort","volume":"37","author":"Yu","year":"2022","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2023.07.002_bib51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SLA.0000000000005071","article-title":"Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients","volume":"274","author":"Delman","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2023.07.002_bib52","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suc.2023.07.002_bib53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/lt.25009","article-title":"What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?","volume":"24","author":"Croome","year":"2018","journal-title":"Liver Transpl"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610923001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610923001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:16:12Z","timestamp":1758539772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610923001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0039610923001123"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2023.07.002","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor Viral Hepatitis and Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2023.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}